SCHEMBL17679028

SCHEMBL17679028

Fc1ccc2oc3ccc(-c4cccc(-n5c6ccccc6c6cc(-c7ccc8c(c7)c7ccccc7n8-c7ccccc7)ccc65)n4)cc3c2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 1/20 0.38
JAK3 P52333 1/20 0.38
KDM4E B2RXH2 1/20 0.36
ATM Q13315 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
PDE10A Q9Y233 2/20 0.35
TNKS O95271 2/20 0.33
CYP1A2 P05177 1/20 0.33
METAP2 P50579 1/20 0.33
SIRT2 Q8IXJ6 1/20 0.32
SIRT1 Q96EB6 1/20 0.32
PTGER4 P35408 1/20 0.32
GABRP O00591 2/20 0.32
GABRD O14764 2/20 0.32
GABRA1 P14867 2/20 0.32
GABRB1 P18505 2/20 0.32
GABRG2 P18507 2/20 0.32
GABRB3 P28472 2/20 0.32
GABRA5 P31644 2/20 0.32
GABRA3 P34903 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17678997 0.97 JAK2 (0.36) JAK2JAK3KDM4EATML3MBTL1
SCHEMBL14770616 0.93 GABRP (0.32) JAK2JAK3PDE10ATNKSCYP1A2
SCHEMBL14770617 0.93 GABRP (0.32) JAK2JAK3PDE10ATNKSCYP1A2
SCHEMBL18158874 0.92 KDM4E (0.39) KDM4EATML3MBTL1SIRT2SIRT1
SCHEMBL17679009 0.90 JAK2 (0.41) JAK2JAK3KDM4EATML3MBTL1
SCHEMBL18560744 0.89 PLA2G2A (0.38) KDM4EATML3MBTL1SIRT2SIRT1
SCHEMBL17679000 0.88 JAK2 (0.39) JAK2JAK3KDM4EATML3MBTL1
SCHEMBL17678980 0.88 KDM4E (0.39) JAK2JAK3KDM4EATML3MBTL1
SCHEMBL17678934 0.87 L3MBTL1 (0.43) JAK2JAK3KDM4EATML3MBTL1
SCHEMBL16452315 0.87 KDM4E (0.35) KDM4EATML3MBTL1SIRT2SIRT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9997719-B2 Material for organic electroluminescence device and organic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 2018-06-12 US disclosed
US-9997719-B2 Material for organic electroluminescence device and organic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 2018-06-12 US disclosed
US-20160104845-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-04-14 US disclosed
US-20160104845-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-04-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160104845-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE SOST, ILK, CACNA2D3 JAK2 4742/4885JAK3 4317/4885KDM4E 1378/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.